AstraZeneca PLC $ 55.44 -0.47 (-0.84%)
Warning! GuruFocus has detected 1 Severe warning sign with AZN. Click here to check it out.
Avg Vol (1m):
Market Cap $:
Enterprise Value $:
Current and historical daily P/E ratio for AZN (AstraZeneca PLC) from 1993 to Sep 22 2020. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. AstraZeneca PLC stock (AZN) PE ratio as of Sep 22 2020 is 65.24. More Details
AstraZeneca PLC PE Ratio (TTM) Historical Data
View and export this data going back to 1993. Start your Free Trial
AstraZeneca PLC PE Ratio (TTM) Comparison
|Company||Market Cap(Mil)||PE Ratio (TTM)|
Compare LSE:GSK LSE:DPH LSE:VEC LSE:CTI NYSE:JNJ XSWX:ROG NYSE:PFE XSWX:NOVN NYSE:MRK NYSE:ABBV NYSE:LLY NYSE:BMY NAS:AMGN XPAR:SAN NAS:GILD TSE:4519 FRA:A60 NYSE:AGN XTER:BAYN SHSE:600276
Traded in other countries AZN.Argentina ZEG.Germany AZNN.Mexico AZN.Sweden AZN.Switzerland AZN.UK AZN.USA
Address 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, GBR, CB2 0AA
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The company sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.